Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 30, Issue 6, 2002, Pages 375-380

  Lo, J W S ^a   Leung, A Y H ^a   Huang, X R ^a   Lie, A K W ^a   Metz, C ^b   Bucala, R ^b   Liang, R ^a   Lan, H Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Acute GVHD; Allogeneic stem cell transplantation; MIF

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; METHOTREXATE;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; ARTICLE; BIOSYNTHESIS; BLOOD; CELL MOTION; CHEMISTRY; COLON; COMPARATIVE STUDY; CYTOLOGY; FEMALE; GENETICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SKIN; T LYMPHOCYTE; UPREGULATION; ALLOIMMUNITY; AUTOTRANSPLANTATION; BLOOD SAMPLING; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GENE EXPRESSION; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MEDIATOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZATION; RECIPIENT; SKIN BIOPSY; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ADULT; CELL MOVEMENT; COLON; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 85047695131     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703639     Document Type: Article

References (27)

1. Krenger W, Hill GR, Ferrara JLM. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553-558.
2. Krenger W, Ferrara JLM. Graft-versus-host disease and the Th1/Th2 paradigm. Immun Res 1996; 15: 50-73.
3. Williamson E, Garside P, Bradley JA, Mowat AM. IL-12 is a central mediator of acute graft-versus-host disease in mice. J Exp Med 1996; 188: 1485-1492.
4. Deeg HJ. Graft-versus-host disease: host and donor views. Semin Hematol 1993; 30 (Suppl. 4): 110-118.
5. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72-77.
6. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80-82.
7. Nishino T, Bernhagen J, Shiiki H et al. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1995; 1: 781-788.
8. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756-759.
9. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-1902.
10. Bacher M, Metz CN, Calandra T et al. An essential regulatory role for macrophage migration inhibitory factor in T cell activation. Proc Natl Acad Sci USA 1996; 93: 7849-7854.
11. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
12. Lan HY, Yang N, Brown FG et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998; 66: 1465-1471.
13. Brown FG, Nikolic-Paterson DJ, Metz C et al. Up-regulation of MIF expression in acute renal allograft rejection in the rat. Clin Exp Immunol 1999; 118: 329-336.
14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
15. Lan HY, Mu W, Yang N et al. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996; 149: 1119-1127.
16. Lan HY, Yang N, Nikolic-Paterson DJ et al. Expression of macrophage migration inhibitory in human glomerulonephritis. Kidney Int 2000; 57: 499-509.
17. Lan HY, Mu W, Nikolin-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102.
18. Lan HY, Mu W, Ng YY, Nikolic-Paterson DJ, Atkins RC. A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem 1996; 44: 281-287.
19. Nathan CF, Kamobsky ML, David JR. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med 1971; 133: 1356-1376.
20. Nathan CF, Remold HG, David JR. Characterization of a lymphocyte factor which alters macrophage function. J Exp Med 1973; 137: 275-288.
21. Bernhagen J, Bacher M, Calandra T et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996; 183: 277-282.
22. Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997; 17: 77-88.
23. Bernhagen J, Calandra T, Cerami A, Bucala R. Macrophage migration inhibitory factor (MIF) is a neuroendocrine mediator of endotoxemia. Trends Microbiol 1994; 2: 198-201.
24. Lan HY, Bacher M, Yang N et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997; 85: 1455-1465.
25. Yang N, Nikolic-Paterson DJ, Ng YY et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production. Mol Med 1998; 4: 413-424.
26. Atkins RC, Nikolic-Paterson DJ, Bucala R, Lan HY. Macrophage migration inhibitory factor (MIF) - potential perspectives for immune-intervention in renal disease. Nephrol Dial Transplant 1998; 13: 2719-1720.
27. Lan HY. Therapeutic effects of cytokine blockade in glomerulonephritis. Nephrol Dial Transplant 1998; 13: 7-9.